BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaukonen D, Kaukonen R, Polit L, Hennessy BT, Lund R, Madden SF. Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression. BMC Med Genomics 2020;13:92. [PMID: 32620123 DOI: 10.1186/s12920-020-00749-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Yuan H, Suzuki S, Terui H, Hirata-Tsuchiya S, Nemoto E, Yamasaki K, Saito M, Shiba H, Aiba S, Yamada S. Loss of IκBζ Drives Dentin Formation via Altered H3K4me3 Status. J Dent Res 2022;:220345221075968. [PMID: 35193410 DOI: 10.1177/00220345221075968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Borkiewicz L. Histone 3 Lysine 27 Trimethylation Signature in Breast Cancer. Int J Mol Sci 2021;22:12853. [PMID: 34884658 DOI: 10.3390/ijms222312853] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Piyawajanusorn C, Nguyen LC, Ghislat G, Ballester PJ. A gentle introduction to understanding preclinical data for cancer pharmaco-omic modeling. Brief Bioinform 2021:bbab312. [PMID: 34368843 DOI: 10.1093/bib/bbab312] [Cited by in F6Publishing: 3] [Reference Citation Analysis]